Global Transdermal Drug Delivery Market to 2020, New Report Launched

 Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

“GLOBAL & USA TRANSDERMAL DRUG DELIVERY MARKET TO 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation” by Kelly Scientific Publications is a dedicated report on the transdermal drug delivery industry and its impact on the USA and global markets. 

This comprehensive report tackles problems that this vertical growing market faces and evaluates saturated sub-markets. A detailed outlay of its major players is performed including business strategy and future development analysis, merger and acquisition tactics, current product and pipeline entry evaluation and a detailed section on each player’s financial situation. This analysis determines the unmet needs of the transdermal drug delivery industry and specific niche areas of market entry.

The transdermal drug delivery market has substantial associations within the smoking cessation market, analgesics/pain market, generics market, neuropathic pain market and also the women’s health market. In the future it will enter the vaccine and gene therapy markets. Transdermal drug delivery is a complex area that has many driving factors including the unmet need for non-invasive drug delivery systems for pediatric, geriatric and dementia patients. 

This report describes the current technologies that are propelling the market space and emerging trials and pipeline agents that will make a significant impact on the industry. It examines the current transdermal delivery systems and how generic competition is allowing penetration of new players in the market and saturation of niche areas.

Financial figures of the drug delivery market and the transdermal drug delivery space are revealed in this report. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. The study also provides a comprehensive financial, business strategy and product review of key players in the transdermal drug delivery industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified. 

In summary, the transdermal drug delivery market has huge opportunities for growth in the areas of dementia (Alzheimer’s & Parkinson’s Disease), generics, paediatrics and geriatrics. Currently the USA is the most prominent market place, followed by Europe, Asia and Emerging Markets. This report will reveal in-depth analysis of the industry and provide cutting-edge intelligence on the current and future spaces it will penetrate.

In 2014, the global drug delivery market (DDM) was worth just under $x billion, a significant jump from $x billion in 2010. The market grew steadily within this time period with a compound annual growth interest of x%. By the end of 2016, it is expected to be worth over $x billion, and make gains to over $x billion by 2020.

Today the US market holds just over x% share, and within the next five years Asian and Emerging market spaces will increase in size. By 2020, the Asian drug delivery market will surge past x%, compared to over x% in Europe. The US total drug delivery market will continue to maintain its x% share by 2020. 

Within the total drug delivery market exists the advanced DDM, which is further segmented into the following niche areas:

• Transdermal
• Transmucosal
• Targeted
• Sustained-released agents
• Prodrugs
• Implants 
• Intrauterine devices
• Oral

Targeted drug delivery is the most significant player within this space, and generated $x billion globally in 2014. Currently, targeted drug delivery systems are indicated in specific cancers, diabetes, tuberculosis and also cardiovascular disorders. These ‘nanocarriers’ are forecast to propel the advanced drug delivery space by an estimated $x million by 2021.

This report is presented as follows:

• By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
• By Geography (Global, USA)
• By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)
• By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain)

A wealth of financial data & business strategy information is provided including:

• Up-to-date company financials, sales & revenue figures
• Revenue and market forecasts
• Business model strategies for drug delivery, pharmaceutical and biotechnology companies
• Comprehensive account of company products, financials & portfolios

SWOT, Economic & Regulatory Environment specifics include:

• Key strengths, weaknesses and threats influencing leading player position within the market
• Technologies driving the market (e.g., chemical enhancers, microneedles)
• Top fastest growing market segments and emerging opportunities
• Top pharmaceutical companies within the market
• Comprehensive product portfolios, R&D activity and pipeline products
• M&A activity and future strategies of top companies
• High demand and unmet need enhances the market
• Challenges of the transdermal drug delivery market

Who should read this report?

• Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
• Industry professionals and business strategists will discover key information to propel their policies
• Investors will gain inside information to dominant players in the industry and future forecasts
• Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment C-Suite professionals, Decision Makers, Business Development professionals

This report will tell you if the companies mentioned are:

• Strong, competitive players
• Pooling their resources for specific growth and therapeutic areas
• Investing strategically in R&D
• Have a history of strategic M&A activity

Benefits of Investing in our Cutting-Edge Reports:

• Clients receive complementary content* with mid-level and enterprise wide licences.
• Post-sale complementary consultation with senior expert analyst is included.
• Use of tables and figures in your own reports and presentations is permitted.
• Each report provides straight-talking strategic analysis & sector intelligence.
• All reports are updated each quarter to give you the most up-to-date information.

Spanning over 280 pages, “Global Transdermal Drug Delivery Market to 2020” report covering the Executive Summary, Transdermal Drug Delivery, Biomechanical and Pharmacological Elements Effecting Transdermal Drug Delivery, Transdermal Drug Delivery Technologies, How Nanotechnology is Transforming Transdermal Drug Delivery, Transdermal Drug Delivery and Disease States. The report covered companies are - 3M, AMAG Pharmaceuticals (Lumara Health, KV Pharm/Ther-Rx Corp), Actavis, Actelion, Ascend Therapeutics, Bayer, Boehringer Ingelheim, Endo International, GlaxoSmithKline, Hercon Pharmaceutical, Janssen Pharmaceuticals

For further information on this report, please visit- http://mrr.cm/4T4

Find all Drug Delivery Reports at: http://www.marketresearchreports.com/drug-delivery